Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Expert Review of Anticancer Therapy|May 12, 2015
When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugsGiuseppina Gallucci, Alfredo Tartarone, Lucia Lombardi, et al.
Life (Basel, Switzerland)|December 23, 2022
Potential Role of Tumor-Derived Exosomes in Non-Small-Cell Lung Cancer in the Era of ImmunotherapyAlfredo Tartarone, Rosa Lerose, Marina Tartarone, et al.
Life (Basel, Switzerland)|May 27, 2023
Current Treatment Approaches for Thymic Epithelial TumorsAlfredo Tartarone, Rosa Lerose, Alessandro Rocco Lettini, et al.
Critical Reviews in Oncology/Hematology|October 25, 2012
The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversyVincenza Conteduca, Giuseppe Di Lorenzo, Alfredo Tartarone, et al.
Medical Oncology (Northwood, London, England)|June 3, 2011
Evaluation of molecular prognostic and predictive factors: an important step towards personalised treatment in non small cell lung cancerAlfredo Tartarone, Rose Lerose, Giuseppina Gallucci, et al.
European Journal of Clinical Pharmacology|December 15, 2011
Off-label use of anti-cancer drugs between clinical practice and research: the Italian experienceRosa Lerose, Pellegrino Musto, Michele Aieta, et al.
Medical Oncology (Northwood, London, England)|June 25, 2014
Which tyrosine kinase inhibitor should be recommended as initial treatment for non-small cell lung cancer patients with EGFR mutations?Alfredo Tartarone, Rosa Lerose, Chiara Lazzari, et al.
Tumori|November 10, 2005
Dose-finding study of weekly docetaxel plus estramustine in patients with hormone-refractory metastatic prostate cancerMariarosa Coccaro, Alfredo Tartarone, Gianpiero Romano, et al.
Journal of Thoracic Disease|August 18, 2020
Cardiovascular risk of smoking and benefits of smoking cessationGiuseppina Gallucci, Alfredo Tartarone, Rosa Lerose, et al.
Pageof 7